QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to advance its QuantiFERON latent tuberculosis ...

As announced April 27, net sales for Q1 2026 rose 2% on a reported basis to $492 million, while sales at constant exchange rates (CER) were down 1%, compared with the outlook for at least 1% CER ...

Venlo, The Netherlands, and Hombrechtikon, Switzerland, Sept. 25, 2024 (GLOBE NEWSWIRE) -- PreAnalytiX GmbH, a joint venture between QIAGEN N.V. (NYSE: QGEN ...

Thank you, Dominica, and good morning, good afternoon, good evening, to all of you. Thanks again for your attention and interest in Qiagen N.V. A year ago, and I hope and I think that most of you ...

Activist Commentary: Fivespan Partners, LP is a San Francisco-based investment firm founded by Dylan Haggart and Sarah Coyne. Prior to Fivespan, Haggart and Coyne were partners at ValueAct Capital and ...

Fintel reports that on April 29, 2026, Baird upgraded their outlook for Qiagen N.V. (NYSE:QGEN) from Neutral to Outperform.

VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a strategic partnership with Servier, a global pharmaceutical group ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Qiagen ...

(RTTNews) - Qiagen NV (QGENF) on Tuesday reported third-quarter net income of $130 million or $0.60 per share, compared to $98 million or $0.44 per share last year. Excluding items, Qiagen NV reported ...

Qiagen NV solutions are used every day by healthcare providers to analyze patient DNA and RNA in order to guide treatment and by researchers pursuing next generation medicine. The opportunity for ...